In ₹ Crore except Per Share Latest Annual	ULTRACEMCO FY26	AMBUJACEM FY26	SHREECEM FY26	ACC FY26	Peer Average
Valuation — at last close
P/E	40.25×	18.52×	47.84×	◆ 10.14×	25.50× +58%
P/B	4.30×	1.48×	3.59×	◆ 1.06×	2.04× +111%
EV/EBITDA	20.63×	15.18×	16.47×	◆ 7.16×	12.94× +59%
Market Cap	₹3.29L Cr	₹87,675 Cr	₹83,417 Cr	₹21,685 Cr	₹64,259 Cr +412%
Growth
Revenue CAGR 3Y	◆ 11.86%	1.45%	5.47%	5.34%	4.09% +190%
Revenue CAGR 5Y	◆ 14.63%	7.02%	9.22%	9.96%	8.73% +68%
Net Income CAGR 3Y	17.30%	23.07%	11.28%	◆ 34.15%	22.83% -24%
Revenue YoY (latest Q)	18.81%	0.25%	◆ 23.85%	-4.09%	6.67% +182%
Net Income YoY (latest Q)	◆ 21.28%	-89.75%	-14.96%	-91.69%	-65.47% +133%
Profitability
EBITDA Margin	19.23%	16.08%	◆ 22.14%	11.36%	16.53% +16%
Net Income Margin	9.25%	◆ 13.87%	8.35%	8.23%	10.15% -9%
Return on Common Equity	◆ 11.08%	8.38%	7.78%	10.93%	9.03% +23%
Return on Capital Employed	◆ 11.85%	4.13%	7.81%	8.83%	6.92% +71%
Return on Assets	5.95%	6.61%	5.83%	◆ 8.07%	6.84% -13%
Credit & Quality
Total Debt/Equity	0.28×	◆ 0.00×	0.07×	0.00×	0.02× +1100%
Interest Coverage	6.61×	13.28×	8.71×	◆ 16.35×	12.78× -48%
Scale — latest FY
Revenue / Total Income	₹88,512 Cr	₹40,656 Cr	₹20,943 Cr	₹25,962 Cr	₹29,187 Cr +203%
Net Income	₹8,188 Cr	₹5,637 Cr	₹1,749 Cr	₹2,137 Cr	₹3,174 Cr +158%
Total Assets	₹1.41L Cr	₹89,607 Cr	₹31,476 Cr	₹27,525 Cr	₹49,536 Cr +185%
EPS	₹277.62	₹19.15	₹483.24	₹113.8	₹205.4 +35%
Book Value per Share	₹2,600.23	₹240.1	₹6,448.87	₹1,093.17	₹2,594.05 0%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 144%.